Researcher slams RadicalNumerics for hyping cancer benchmark gains without trials

anshulkundaje · x · 2026-09-09

jmschreiber91 criticizes RadicalNumerics for advertising a benchmark improvement while immediately caveatting that "this is actually way more complicated and we aren't doing clinical trials or anything real." He argues that with cancer being serious, this kind of hype-then-disclaim framing is misleading and frustrating.

Original post →

More from Fun

Fun channel →